EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting.
Many recent publications in nuclear medicine contain data on dosimetric findings for existing and new diagnostic and therapeutic agents. In many of these articles, however, a description of the methodology applied for dosimetry is lacking or important details are omitted. The intention of the EANM Dosimetry Committee is to guide the reader through a series of suggestions for reporting dosimetric approaches. The authors are aware of the large amount of data required to report the way a given clinical dosimetry procedure was implemented. Another aim of this guidance document is to provide comprehensive information for preparing and submitting publications and reports containing data on internal dosimetry. This guidance document also contains a checklist which could be useful for reviewers of manuscripts submitted to scientific journals or for grant applications. In addition, this document could be used to decide which data are useful for a documentation of dosimetry results in individual patient records. This may be of importance when the approval of a new radiopharmaceutical by official bodies such as EMA or FDA is envisaged.
Lassmann
M
M
Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. Lassmann_m@klinik.uni-wuerzburg.de
Chiesa
C
C
Flux
G
G
Bardiès
M
M
D002138:Calibration; D003952:Diagnostic Imaging; D004282:Documentation; D015902:Gamma Cameras; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007700:Kinetics; D009369:Neoplasms; D019047:Phantoms, Imaging; D011829:Radiation Dosage; D011874:Radiometry / Q000295:instrumentation / Q000379:methods*; D019275:Radiopharmaceuticals; D012107:Research Design
D019275:Radiopharmaceuticals
Phys Med Biol. 2010 Feb 7;55(3):817-31
20071766
Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1405-12
18491092
Cancer Biother Radiopharm. 2005 Feb;20(1):66-71
15778583
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1037-48
19288099
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):354-61
12634962
J Nucl Med. 2005 Oct;46(10):1679-86
16204718
J Nucl Med. 2005 Jun;46(6):1023-7
15937315
J Nucl Med. 1999 Aug;40(8):1337-41
10450686
J Nucl Med. 1993 Dec;34(12):2216-21
8254414
Phys Med Biol. 2002 Sep 7;47(17):3211-23
12361219
Med Phys. 2007 Nov;34(11):4285-92
18072493
J Nucl Med. 2004 Apr;45(4):619-25
15073258
Q J Nucl Med Mol Imaging. 2009 Dec;53(6):658-70
20016456
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1408-25
19936745
Phys Med Biol. 1996 Oct;41(10):1871-84
8912367
Cancer Biother Radiopharm. 2005 Apr;20(2):195-9
15869455
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):611-23
17929014
Phys Med Biol. 2010 Apr 21;55(8):2365-98
20360631
J Nucl Med. 2009 Feb;50(2):316-23
19164237
Nat Biotechnol. 2008 Jan;26(1):28-9
18183010
Med Phys. 2009 Feb;36(2):612-9
19292001
Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):662-71
20130859
J Nucl Med. 2005 Jan;46 Suppl 1:128S-40S
15653661
J Nucl Med. 2009 Mar;50(3):477-84
19258258
Nuklearmedizin. 2008;47(3):120-6
18493692
Cancer Biother Radiopharm. 2008 Feb;23(1):53-64
18298329